FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RIFABUTIN
异名/同义词1',4-DIDEHYDRO-1-DEOXY-1,4-DIHYDRO-5'-(2-METHYLPROPYL)-1-OXORIFAMYCIN XIV
4-DEOXO-3,4-(2-SPIRO-(N-ISOBUTYL-4-PIPERIDYL))-(1H)-IMIDAZO-(2,5-DIHYDRO)RIFAMYCIN S
4-N-ISOBUTYLSPIROPIPERIDYLRIFAMYCIN S
ANSAMYCIN
LM 427
LM-427
MYCOBUTIN
RIFABUTIN
RIFABUTIN [EP MONOGRAPH]
RIFABUTIN [HSDB]
RIFABUTIN [INN]
RIFABUTIN [JAN]
RIFABUTIN [MART.]
RIFABUTIN [MI]
RIFABUTIN [ORANGE BOOK]
RIFABUTIN [USAN]
RIFABUTIN [USP MONOGRAPH]
RIFABUTIN [USP-RS]
RIFABUTIN [VANDF]
RIFABUTIN [WHO-DD]
TALICIA COMPONENT RIFABUTIN
CAS登记号72559-06-9
物质唯一标识(Unique Ingredient Identifier)1W306TDA6S
分子式C46H62N4O11
国际化合物标识(International Chemical Identifier,InChI)ATEBXHFBFRCZMA-VXTBVIBXSA-N
SMILESC12=C3C(=NC4(N3)CCN(CC4)CC(C)C)c5c(C1=O)c(c(c6O[C@@](C(c56)=O)(O/C=C/[C@@H]([C@@H](C)[C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(N2)=O)/C)C)O)C)O)C)OC(=O)C)OC)C)C)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System